"cancer immunotherapy" trang 3 - tải miễn phí từ tailieuXANH
Emerging avenues in immunotherapy for the management of malignant pleural mesothelioma

Emerging avenues in immunotherapy for the management of malignant pleural mesothelioma
24    40    1
Báo cáo y học:

Báo cáo y học: "Cancer immunotherapy by immunosuppression"
9    51    0
báo cáo khoa học:

báo cáo khoa học: "Ovarian cancer immunotherapy: opportunities, progresses and challenges"
11    53    0
Báo cáo y học:

Báo cáo y học: " Eradication of intractable malignant ascites by abdominocentesis, reinfusion of concentrated ascites, and adoptive immunotherapy with dendritic cells and activated killer cells in a patient with recurrent lung cancer: a case report"
7    38    0
Báo cáo hóa học:

Báo cáo hóa học: " miR-17-92 expression in differentiated T cells - implications for cancer immunotherapy"
12    66    0
Báo cáo sinh học:

Báo cáo sinh học: "Guiding cancer immunotherapy from bench to bedside"
6    35    0
Immunological effects of nivolumab immunotherapy in patients with oral cavity squamous cell carcinoma

Immunological effects of nivolumab immunotherapy in patients with oral cavity squamous cell carcinoma
10    65    0
Convection-enhanced delivery of temozolomide and whole cell tumor immunizations in GL261 and KR158 experimental mouse gliomas

Convection-enhanced delivery of temozolomide and whole cell tumor immunizations in GL261 and KR158 experimental mouse gliomas
12    64    0
Hyperprogression after immunotherapy in patients with malignant tumors of digestive system

Hyperprogression after immunotherapy in patients with malignant tumors of digestive system
9    41    0
Exceptional response to chemotherapy followed by concurrent radiotherapy and immunotherapy in a male with primary retroperitoneal serous Adenocarcinoma: A case report and literature review

Exceptional response to chemotherapy followed by concurrent radiotherapy and immunotherapy in a male with primary retroperitoneal serous Adenocarcinoma: A case report and literature review
7    57    0
Generation of dual specific bivalent BiTEs (dbBIspecific T-cell engaging antibodies) for cellular immunotherapy

Generation of dual specific bivalent BiTEs (dbBIspecific T-cell engaging antibodies) for cellular immunotherapy
14    50    0
CD171- and GD2-specific CAR-T cells potently target retinoblastoma cells in preclinical in vitro testing

CD171- and GD2-specific CAR-T cells potently target retinoblastoma cells in preclinical in vitro testing
17    81    0
Phase I study of an active immunotherapy for asymptomatic phase Lymphoplasmacytic lymphoma with DNA vaccines encoding antigen-chemokine fusion: Study protocol

Phase I study of an active immunotherapy for asymptomatic phase Lymphoplasmacytic lymphoma with DNA vaccines encoding antigen-chemokine fusion: Study protocol
9    81    0
Clinical decision making in the era of immunotherapy for high grade-glioma: Report of four cases

Clinical decision making in the era of immunotherapy for high grade-glioma: Report of four cases
9    53    0
Retrospective analysis of the immunogenic effects of intra-arterial locoregional therapies in hepatocellular carcinoma: A rationale for combining selective internal radiation therapy (SIRT) and immunotherapy

Retrospective analysis of the immunogenic effects of intra-arterial locoregional therapies in hepatocellular carcinoma: A rationale for combining selective internal radiation therapy (SIRT) and immunotherapy
10    71    0
Challenges of driving CD30-directed CAR-T cells to the clinic

Challenges of driving CD30-directed CAR-T cells to the clinic
8    71    0
The efficacy and safety of anti-CD19/CD20 chimeric antigen receptor- T cells immunotherapy in relapsed or refractory B-cell malignancies: A meta-analysis

The efficacy and safety of anti-CD19/CD20 chimeric antigen receptor- T cells immunotherapy in relapsed or refractory B-cell malignancies: A meta-analysis
13    49    0
Precision medicine phase II study evaluating the efficacy of a double immunotherapy by durvalumab and tremelimumab combined with olaparib in patients with solid cancers and carriers of homologous recombination repair genes mutation in response or stable after olaparib treatment

Precision medicine phase II study evaluating the efficacy of a double immunotherapy by durvalumab and tremelimumab combined with olaparib in patients with solid cancers and carriers of homologous recombination repair genes mutation in response or stable after olaparib treatment
10    46    0
Predicting clinical outcomes in chordoma patients receiving immunotherapy: A comparison between volumetric segmentation and RECIST

Predicting clinical outcomes in chordoma patients receiving immunotherapy: A comparison between volumetric segmentation and RECIST
9    58    0
Improving immunological tumor microenvironment using electro-hyperthermia followed by dendritic cell immunotherapy

Improving immunological tumor microenvironment using electro-hyperthermia followed by dendritic cell immunotherapy
11    76    0
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.